Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hauser

Showing results (191-200 of 419) with videos related to

Pageof 42
Sort By:
The Journal of Clinical Investigation|December 1, 1995
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primateC P Genain, M H Nguyen, N L Letvin, et al.
Brain : a Journal of Neurology|August 31, 2010
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosisSergio E Baranzini, Radhika Srinivasan, Pouya Khankhanian, et al.
Journal of Biomolecular Structure & Dynamics|January 10, 2001
Biomesogenic matrix systemsW V Meister, S Lindau, A L Hauser, et al.
Annals of Clinical and Translational Neurology|January 13, 2017
Onset of secondary progressive MS after long-term rituximab therapy - a case reportH-Christian von Büdingen, Antje Bischof, Erica L Eggers, et al.
Plos Pathogens|August 21, 2025
DCLK1 isoform (DCLK1-S) as a critical player in promoting inflammation, tissue remodeling, and EMT in mouse models of colitisKafayat Yusuf, Badal C Roy, William L Hauser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchusA Uccelli, J R Oksenberg, M C Jeong, et al.
Genes and Immunity|March 6, 2003
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosisU Sriram, L F Barcellos, P Villoslada, et al.
The New England Journal of Medicine|January 27, 1983
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTHS L Hauser, D M Dawson, J R Lehrich, et al.
Neurology|September 3, 2021
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple SclerosisStephen L Hauser, Ludwig Kappos, Xavier Montalban, et al.
Neurology. Clinical Practice|September 6, 2021
Electronic Health Record Technology Designed for the Clinical Encounter: MS NeuroShareRiley Bove, Christa A Bruce, Chelsea K Lunders, et al.
Pageof 42

Showing results (191-200 of 419) with videos related to

Sort By:
Pageof 42
The Journal of Clinical Investigation|December 1, 1995
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primateC P Genain, M H Nguyen, N L Letvin, et al.
Brain : a Journal of Neurology|August 31, 2010
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosisSergio E Baranzini, Radhika Srinivasan, Pouya Khankhanian, et al.
Journal of Biomolecular Structure & Dynamics|January 10, 2001
Biomesogenic matrix systemsW V Meister, S Lindau, A L Hauser, et al.
Annals of Clinical and Translational Neurology|January 13, 2017
Onset of secondary progressive MS after long-term rituximab therapy - a case reportH-Christian von Büdingen, Antje Bischof, Erica L Eggers, et al.
Plos Pathogens|August 21, 2025
DCLK1 isoform (DCLK1-S) as a critical player in promoting inflammation, tissue remodeling, and EMT in mouse models of colitisKafayat Yusuf, Badal C Roy, William L Hauser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchusA Uccelli, J R Oksenberg, M C Jeong, et al.
Genes and Immunity|March 6, 2003
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosisU Sriram, L F Barcellos, P Villoslada, et al.
The New England Journal of Medicine|January 27, 1983
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTHS L Hauser, D M Dawson, J R Lehrich, et al.
Neurology|September 3, 2021
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple SclerosisStephen L Hauser, Ludwig Kappos, Xavier Montalban, et al.
Neurology. Clinical Practice|September 6, 2021
Electronic Health Record Technology Designed for the Clinical Encounter: MS NeuroShareRiley Bove, Christa A Bruce, Chelsea K Lunders, et al.
Pageof 42